Michael Kauffman's Net Worth
Estimate Recalculated Nov 8, 2024 09:38PM EST
Who is Michael Kauffman
Michael Kauffman has an estimated net worth of $9.68 Million. This is based on reported shares across multiple companies, which include Kezar Life Sciences, Inc., Adicet Bio, Inc., Verastem, Inc., Karyopharm Therapeutics Inc., INFINITY PHARMACEUTICALS, INC., COMBINATORX, INC, ONYX PHARMACEUTICALS INC, and BIOENVISION INC.
SEC CIK
Michael Kauffman's CIK is 0001364719
Past Insider Trading and Trends
2018 was Michael Kauffman's most active year for acquiring shares with 19 total transactions. Michael Kauffman's most active month to acquire stocks was the month of May. 2018 was Michael Kauffman's most active year for disposing of shares, totalling 28 transactions. Michael Kauffman's most active month to dispose stocks was the month of February. 2019 saw Michael Kauffman paying a total of $190,080.00 for 422,296 shares, this is the most they've acquired in one year. In 2014 Michael Kauffman cashed out on 110,000 shares for a total of $4,681,523.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
